Marine Phytoplankton Bioactive Lipids and Their Perspectives in Clinical Inflammation
Marine Drugs · 2025
DOI: 10.3390/md23020086 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, 2025. Verfasst von Edoardo Andrea Cutolo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Photosynthesis and Bioenergy, Department of Biotechnology, University of Verona, Strada le Grazie 15, 37134 Verona, Italy. Hauptthemen laut MEDLINE: Phytoplankton, Lipids, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 264 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Marine phytoplankton is an emerging source of immunomodulatory bioactive lipids (BLs). Under physiological growth conditions and upon stress challenges, several eukaryotic microalgal species accumulate lipid metabolites that resemble the precursors of animal mediators of inflammation: eicosanoids and prostaglandins. Therefore, marine phytoplankton could serve as a biotechnological platform to produce functional BLs with therapeutic applications in the management of chronic inflammatory diseases and other clinical conditions. However, to be commercially competitive, the lipidic precursor yields should be enhanced. Beside tailoring the cultivation of native producers, genetic engineering is a feasible strategy to accrue the production of lipid metabolites and to introduce heterologous biosynthetic pathways in microalgal hosts. Here, we present the state-of-the-art clinical research on immunomodulatory lipids from eukaryotic marine phytoplankton and discuss synthetic biology approaches to boost their light-driven biosynthesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Photosynthesis and Bioenergy, Department of Biotechnology, University of Verona, Strada le Grazie 15, 37134 Verona, Italy.
- Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, 16132 Genova, Italy.
- IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
- Stazione Zoologica Anton Dohrn Napoli, Ecosustainable Marine Biotechnology Department, Via Ammiraglio Ferdinando Acton 55, 80133 Napoli, Italy.
- Institute of Molecular Biosciences, Goethe University Frankfurt am Main, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany.
ORCID-Profile: Edoardo Andrea Cutolo, Rosanna Campitiello, Valeria Di Dato, Ida Orefice, Max Angstenberger, Maurizio Cutolo
Zitieren
APA
Cutolo, E. A., Campitiello, R., Di Dato, V., Orefice, I., Angstenberger, M., & Cutolo, M. (2025). Marine Phytoplankton Bioactive Lipids and Their Perspectives in Clinical Inflammation. Marine Drugs. https://doi.org/10.3390/md23020086
Vancouver
Cutolo EA, Campitiello R, Di Dato V, Orefice I, Angstenberger M, Cutolo M. Marine Phytoplankton Bioactive Lipids and Their Perspectives in Clinical Inflammation. Marine Drugs. 2025. doi:10.3390/md23020086
BibTeX
@article{Cutolo2025,
author = {Cutolo, Edoardo Andrea and Campitiello, Rosanna and Di Dato, Valeria and Orefice, Ida and Angstenberger, Max and Cutolo, Maurizio},
title = {Marine Phytoplankton Bioactive Lipids and Their Perspectives in Clinical Inflammation},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23020086}
}
EUVIMED